Brief: HCW Biologics Granted Third Fundamental Patent
14/06/2023 12:37
June 14 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS IS GRANTED THIRD FUNDAMENTAL PATENT: U.S.
PATENT
FOR METHODS OF TREATING AGE-RELATED DISORDERS
Source text for Eikon: ID:nGNX4gZdfB
Further company coverage: HCWB.O
(reuters.briefs@thomsonreuters.com)
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM